FRISCO, Texas and TEMPE, Ariz., Jan. 16, 2026 /PRNewswire/ — AllyGPO® and BioCareSD®, a strategic partnership serving community-based specialty practices, todayFRISCO, Texas and TEMPE, Ariz., Jan. 16, 2026 /PRNewswire/ — AllyGPO® and BioCareSD®, a strategic partnership serving community-based specialty practices, today

AllyGPO and BioCareSD Welcome Retina Associates of Cleveland, Highlighting the Market Need for New Transparent, Technology-Forward Options

FRISCO, Texas and TEMPE, Ariz., Jan. 16, 2026 /PRNewswire/ — AllyGPO® and BioCareSD®, a strategic partnership serving community-based specialty practices, today announced that Retina Associates of Cleveland, Inc (RACI) has selected BioCareSD for specialty distribution (SD) and AllyGPO for group purchasing organization (GPO) services. This relationship expands AllyGPO and BioCareSD’s growing national footprint in community retina and reflects increasing demand for alternative GPO and SD options that offer more transparent, technology-enabled drug management.

Founded in 1974 and celebrating more than 50 years of patient care, RACI is widely regarded as one of Ohio’s premier retina specialty practices. The practice is known for its leadership in clinical research and expertise in advanced treatments for age-related macular degeneration, diabetic retinopathy, retinal tears and detachments, and other complex retinal conditions.

“Maintaining our independence is central to how RACI cares for patients, and we value partners who support this,” said President of RACI David G. Miller, MD. “BioCareSD and AllyGPO, through consistent actions and collaboration, have demonstrated their genuine commitment to preserving community retina practice independence in meaningful, practical ways. Choosing to partner with them enables RACI to better manage day-to-day operational and financial demands while securing long-term resilience with more efficient workflows and greater visibility from data-driven analytics.”

AllyGPO and BioCareSD provide RACI with high-touch specialty distribution and GPO services designed specifically for modern community retina practices. Key considerations in RACI’s decision included supply reliability, transparency in drug pricing, more timely, accurate GPO contract rebates, and responsive, consultative support from a dedicated retina team that works closely with clinical and administrative teams.

Another differentiator was AllyGPO and BioCareSD’s technology-forward approach, including AllyIQ®, AllyGPO’s comprehensive specialty drug management platform. By integrating data from practices’ core operational systems and BioCareSD’s ordering site, AllyIQ supports informed decision making with clear, actionable insights into purchasing, inventory, and utilization.

“RACI exemplifies the kind of physician-led practice that AllyGPO was built to serve,” remarked Brian Ansay, CEO of AllyGPO. “Our role as a GPO is to provide insight and hands-on support that helps members navigate complexity, confidently make data-driven decisions, and firmly remain in control of their future.”

“Retina Associates of Cleveland is a highly respected practice with a longstanding reputation for clinical excellence and physician leadership,” said Jennifer Waters, SVP of Retina at BioCareSD. “Their decision to partner with us reinforces that the market is seeking more transparent, flexible, and technology-enabled distribution and GPO partners built specifically around the needs of community retina practices.” 

The addition of RACI reflects AllyGPO and BioCareSD’s continued growth in community retina, as practices seek support in navigating rising drug costs, payer pressures, new biosimilar introductions, increasing administrative complexity, and distributors’ acquisition of practices. To learn more, visit www.NewRetinaPartner.com.

About Retina Associates of Cleveland, Inc.
Retina Associates of Cleveland, Inc (RACI) is the largest retina practice in Ohio. Since 1974, the practice has striven to improve the quality of life for every patient by preserving their best vision possible. With 17 retinal specialists, 13 northeast Ohio locations, and continual clinical trials, the community has access to world-renowned expert retinal care.

About AllyGPO
AllyGPO is a tech-forward group purchasing organization empowering community practices to operate more efficiently, improve practice economics, and remain independent through AllyRetina, its dedicated retina service, and AllyIQ®, its comprehensive drug management platform combining inventory management, GPO contract optimization, and advanced analytics. www.AllyGPO.com.

About BioCareSD
BioCareSD, a BioCare company, is a national specialty distributor with over 40 years of experience delivering life-changing specialty therapies. Committed to redefining specialty distribution, BioCareSD focuses on trust, transparency, and operational excellence. The company provides high-touch, personalized service through a dedicated support team and 24/7/365 customer care. Its distribution model and expanding portfolio support partners in delivering care. www.biocaresd.com.

Media Contact:
Dara Shulman
407766@email4pr.com
866-255-9476

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/allygpo-and-biocaresd-welcome-retina-associates-of-cleveland-highlighting-the-market-need-for-new-transparent-technology-forward-options-302663422.html

SOURCE AllyGPO and BioCareSD

Market Opportunity
Stader Logo
Stader Price(SD)
$0.2028
$0.2028$0.2028
-4.42%
USD
Stader (SD) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Why Vitalik Buterin Just Pulled 16,384 ETH From His Holdings

Why Vitalik Buterin Just Pulled 16,384 ETH From His Holdings

The post Why Vitalik Buterin Just Pulled 16,384 ETH From His Holdings appeared first on Coinpedia Fintech News Ethereum co-founder Vitalik Buterin just withdrew
Share
CoinPedia2026/01/30 18:19
Record-breaking streak ends – Rabobank

Record-breaking streak ends – Rabobank

The post Record-breaking streak ends – Rabobank appeared on BitcoinEthereumNews.com. Rabobank’s report notes that Gold has seen a significant retracement, ending
Share
BitcoinEthereumNews2026/01/30 18:24
World Liberty Financial Approves WLFI Token Buyback Plan

World Liberty Financial Approves WLFI Token Buyback Plan

The post World Liberty Financial Approves WLFI Token Buyback Plan appeared on BitcoinEthereumNews.com. Key Points: WLFI plans significant token buyback. Buyback aims to enhance token value. 99.84% approval received for the strategy. World Liberty Financial’s governance proposal mandates using all liquidity fees for WLFI token buybacks and permanent removal, receiving 99.84% voter support by September 19, 2025. This initiative aims to boost WLFI’s price stability, targeting committed investors, amid volatile market conditions post-launch. WLFI Buyback Gains Overwhelming 99.84% Support World Liberty Financial (WLFI) announced a significant governance decision regarding its native token. With a notable 99.84% voter approval, all liquidity-generated fees will fund buybacks and permanent burns of WLFI tokens, enhancing long-term value. This effort marks a substantial shift in the project’s financial strategy, as the Trump family continues to play a shaping role with their association. The immediate results of this vote are expected to stabilize WLFI’s price, which experienced turbulence after its introduction. The strategy’s broader goal is to remove circulating tokens that participants not aligned with WLFI’s long-term goals hold, thereby improving value for those invested long-term. Market analysts anticipate that a consistent buyback-and-burn approach could strengthen WLFI’s market position, despite no formal endorsements from major regulatory bodies. However, notable community figures, including influential investors, have voiced both support and reservations regarding the plan’s impact on market dynamics. Lookonchain Analysis: Recent Trends in Crypto Transactions highlights a similar trend in interest within the broader cryptocurrency market. WLFI’s Market Outlook Following Buyback Strategy Did you know? Advanced buyback strategies similar to World Liberty Financial’s approach have observed increased adoption in 2024, offering short-term price boosts and encouraging long-term token holding, especially during volatile periods. World Liberty Financial’s WLFI token recently saw a 0.67% increase in 24 hours, reaching $0.23, with a market cap of $5.54 billion according to CoinMarketCap. Trading volume dropped by 48.92%, yet over the past seven days, WLFI…
Share
BitcoinEthereumNews2025/09/21 06:41